These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

139 related articles for article (PubMed ID: 26854376)

  • 1. Non-symmetrical furan-amidines as novel leads for the treatment of cancer and malaria.
    Alnabulsi S; Santina E; Russo I; Hussein B; Kadirvel M; Chadwick A; Bichenkova EV; Bryce RA; Nolan K; Demonacos C; Stratford IJ; Freeman S
    Eur J Med Chem; 2016 Mar; 111():33-45. PubMed ID: 26854376
    [TBL] [Abstract][Full Text] [Related]  

  • 2. Evaluation of analogues of furan-amidines as inhibitors of NQO2.
    Alnabulsi S; Hussein B; Santina E; Alsalahat I; Kadirvel M; Magwaza RN; Bryce RA; Schwalbe CH; Baldwin AG; Russo I; Stratford IJ; Freeman S
    Bioorg Med Chem Lett; 2018 May; 28(8):1292-1297. PubMed ID: 29567345
    [TBL] [Abstract][Full Text] [Related]  

  • 3. Investigation into novel thiophene- and furan-based 4-amino-7-chloroquinolines afforded antimalarials that cure mice.
    Opsenica IM; Verbić TŽ; Tot M; Sciotti RJ; Pybus BS; Djurković-Djaković O; Slavić K; Šolaja BA
    Bioorg Med Chem; 2015 May; 23(9):2176-86. PubMed ID: 25801154
    [TBL] [Abstract][Full Text] [Related]  

  • 4. Antimalarial agents against both sexual and asexual parasites stages: structure-activity relationships and biological studies of the Malaria Box compound 1-[5-(4-bromo-2-chlorophenyl)furan-2-yl]-N-[(piperidin-4-yl)methyl]methanamine (MMV019918) and analogues.
    Vallone A; D'Alessandro S; Brogi S; Brindisi M; Chemi G; Alfano G; Lamponi S; Lee SG; Jez JM; Koolen KJM; Dechering KJ; Saponara S; Fusi F; Gorelli B; Taramelli D; Parapini S; Caldelari R; Campiani G; Gemma S; Butini S
    Eur J Med Chem; 2018 Apr; 150():698-718. PubMed ID: 29571157
    [TBL] [Abstract][Full Text] [Related]  

  • 5. Synthesis and in vitro biological evaluation of dihydroartemisinyl-chalcone esters.
    Smit FJ; van Biljon RA; Birkholtz LM; N'Da DD
    Eur J Med Chem; 2015 Jan; 90():33-44. PubMed ID: 25461309
    [TBL] [Abstract][Full Text] [Related]  

  • 6. Synthesis, In Vitro Antitumor Activity and Molecular Mechanism of Novel Furan Derivatives and their Precursors.
    Lu D; Zhou Y; Li Q; Luo J; Jiang Q; He B; Tang Q
    Anticancer Agents Med Chem; 2020; 20(12):1475-1486. PubMed ID: 32329695
    [TBL] [Abstract][Full Text] [Related]  

  • 7. Structure-based design and synthesis of novel furan-diketopiperazine-type derivatives as potent microtubule inhibitors for treating cancer.
    Ding Z; Li F; Zhong C; Li F; Liu Y; Wang S; Zhao J; Li W
    Bioorg Med Chem; 2020 May; 28(10):115435. PubMed ID: 32278711
    [TBL] [Abstract][Full Text] [Related]  

  • 8. Novel Peroxides as Promising Anticancer Agents with Unexpected Depressed Antimalarial Activity.
    Coghi P; Yaremenko IA; Prommana P; Radulov PS; Syroeshkin MA; Wu YJ; Gao JY; Gordillo FM; Mok S; Wong VKW; Uthaipibull C; Terent'ev AO
    ChemMedChem; 2018 May; 13(9):902-908. PubMed ID: 29469179
    [TBL] [Abstract][Full Text] [Related]  

  • 9. Design, synthesis and biological evaluation of novel benzimidazole amidines as potent multi-target inhibitors for the treatment of non-small cell lung cancer.
    Bistrović A; Krstulović L; Harej A; Grbčić P; Sedić M; Koštrun S; Pavelić SK; Bajić M; Raić-Malić S
    Eur J Med Chem; 2018 Jan; 143():1616-1634. PubMed ID: 29133046
    [TBL] [Abstract][Full Text] [Related]  

  • 10. 2,4-Diphenyl furan diamidines as novel anti-Pneumocystis carinii pneumonia agents.
    Francesconi I; Wilson WD; Tanious FA; Hall JE; Bender BC; Tidwell RR; McCurdy D; Boykin DW
    J Med Chem; 1999 Jun; 42(12):2260-5. PubMed ID: 10377232
    [TBL] [Abstract][Full Text] [Related]  

  • 11. Design, synthesis, in vitro and in vivo biological evaluation of 2-amino-3-aroylbenzo[b]furan derivatives as highly potent tubulin polymerization inhibitors.
    Oliva P; Romagnoli R; Manfredini S; Brancale A; Ferla S; Hamel E; Ronca R; Maccarinelli F; Giacomini A; Rruga F; Mariotto E; Viola G; Bortolozzi R
    Eur J Med Chem; 2020 Aug; 200():112448. PubMed ID: 32417696
    [TBL] [Abstract][Full Text] [Related]  

  • 12. Design, synthesis, molecular docking and cytotoxic evaluation of novel 2-furybenzimidazoles as VEGFR-2 inhibitors.
    Abdullaziz MA; Abdel-Mohsen HT; El Kerdawy AM; Ragab FAF; Ali MM; Abu-Bakr SM; Girgis AS; El Diwani HI
    Eur J Med Chem; 2017 Aug; 136():315-329. PubMed ID: 28505536
    [TBL] [Abstract][Full Text] [Related]  

  • 13. Synthesis of pyrazole acrylic acid based oxadiazole and amide derivatives as antimalarial and anticancer agents.
    Verma G; Chashoo G; Ali A; Khan MF; Akhtar W; Ali I; Akhtar M; Alam MM; Shaquiquzzaman M
    Bioorg Chem; 2018 Apr; 77():106-124. PubMed ID: 29353728
    [TBL] [Abstract][Full Text] [Related]  

  • 14. The synthesis and evaluation of thymoquinone analogues as anti-ovarian cancer and antimalarial agents.
    Johnson-Ajinwo OR; Ullah I; Mbye H; Richardson A; Horrocks P; Li WW
    Bioorg Med Chem Lett; 2018 Apr; 28(7):1219-1222. PubMed ID: 29519737
    [TBL] [Abstract][Full Text] [Related]  

  • 15. Synthesis and Anticancer Activity of New ((Furan-2-yl)-1,3,4-thiadiazolyl)-1,3,4-oxadiazole Acyclic Sugar Derivatives.
    Kassem AF; Nassar IF; Abdel-Aal MT; Awad HM; El-Sayed WA
    Chem Pharm Bull (Tokyo); 2019; 67(8):888-895. PubMed ID: 31366838
    [TBL] [Abstract][Full Text] [Related]  

  • 16. Synthesis of 1-(3',4',5'-trimethoxy) phenyl naphtho[2,1b]furan as a novel anticancer agent.
    Srivastava V; Negi AS; Kumar JK; Faridi U; Sisodia BS; Darokar MP; Luqman S; Khanuja SP
    Bioorg Med Chem Lett; 2006 Feb; 16(4):911-4. PubMed ID: 16297622
    [TBL] [Abstract][Full Text] [Related]  

  • 17. Discovery of harmiprims, harmine-primaquine hybrids, as potent and selective anticancer and antimalarial compounds.
    Pavić K; Poje G; Pessanha de Carvalho L; Tandarić T; Marinović M; Fontinha D; Held J; Prudêncio M; Piantanida I; Vianello R; Krošl Knežević I; Perković I; Rajić Z
    Bioorg Med Chem; 2024 May; 105():117734. PubMed ID: 38677112
    [TBL] [Abstract][Full Text] [Related]  

  • 18. Novel inhibitors of Plasmodium falciparum based on 2,5-disubstituted furans.
    Krake SH; Martinez PDG; McLaren J; Ryan E; Chen G; White K; Charman SA; Campbell S; Willis P; Dias LC
    Eur J Med Chem; 2017 Jan; 126():929-936. PubMed ID: 28002775
    [TBL] [Abstract][Full Text] [Related]  

  • 19. Identification, design and biological evaluation of bisaryl quinolones targeting Plasmodium falciparum type II NADH:quinone oxidoreductase (PfNDH2).
    Pidathala C; Amewu R; Pacorel B; Nixon GL; Gibbons P; Hong WD; Leung SC; Berry NG; Sharma R; Stocks PA; Srivastava A; Shone AE; Charoensutthivarakul S; Taylor L; Berger O; Mbekeani A; Hill A; Fisher NE; Warman AJ; Biagini GA; Ward SA; O'Neill PM
    J Med Chem; 2012 Mar; 55(5):1831-43. PubMed ID: 22364416
    [TBL] [Abstract][Full Text] [Related]  

  • 20. Synthesis and antiprotozoal activity of 2,5-bis(4-guanylphenyl)furans.
    Das BP; Boykin DW
    J Med Chem; 1977 Apr; 20(4):531-6. PubMed ID: 321783
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 7.